0001127602-12-032064.txt : 20121126
0001127602-12-032064.hdr.sgml : 20121126
20121126182745
ACCESSION NUMBER: 0001127602-12-032064
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20121121
FILED AS OF DATE: 20121126
DATE AS OF CHANGE: 20121126
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAY RUSSELL T
CENTRAL INDEX KEY: 0001225960
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10269
FILM NUMBER: 121225221
MAIL ADDRESS:
STREET 1: 2525 DUPONT DR
CITY: IRVINE
STATE: CA
ZIP: 92612
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALLERGAN INC
CENTRAL INDEX KEY: 0000850693
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 951622442
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 DUPONT DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: 7142464500
MAIL ADDRESS:
STREET 1: P.O. BOX 19534
CITY: IRVINE
STATE: CA
ZIP: 92713-9534
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2012-11-21
0000850693
ALLERGAN INC
AGN
0001225960
RAY RUSSELL T
2525 DUPONT DRIVE
IRVINE
CA
92612
1
Common Stock
2012-11-21
4
S
0
18000
91.046
D
22800
D
Common Stock
2012-11-21
4
M
0
5000
36.85
A
27800
D
Common Stock
2012-11-21
4
M
0
5000
45.885
A
32800
D
Common Stock
2012-11-21
4
M
0
5000
36.49
A
37800
D
Common Stock
2012-11-21
4
S
0
15000
91.0491
D
22800
D
Nonemployee Director Stock Option (Right to Buy)
36.85
2012-11-21
4
M
0
5000
0
D
2004-04-25
2013-04-24
Common Stock
5000
0
D
Nonemployee Director Stock Option (Right to Buy)
45.885
2012-11-21
4
M
0
5000
0
D
2005-04-28
2014-04-28
Common Stock
5000
0
D
Nonemployee Director Stock Option (Right to Buy)
36.49
2012-11-21
4
M
0
5000
0
D
2006-04-26
2015-04-26
Common Stock
5000
0
D
The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.35, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote
The price reported in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $90.79 to $91.35, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote
/s/ Matthew J. Maletta, Attorney-in-Fact for Russell T. Ray
2012-11-26